David Kerr

Current

• Senior Investigator, Diabetes Research and Digital Health, Sutter Center for Health Systems Research
• Associate Editor, Journal of Diabetes Science and Technology
• Adjunct Professor, Dept Electrical and Computer Engineering, Rice University
• Scientific Advisory Board, PATHS-UP (https://pathsup.org)
• Co-Chair, Innovation sub-group, NIDDK Working Group of Council on the Heterogeneity of Diabetes

PREVIOUSLY

• Research Committee, Association of Diabetes Care and Education Specialists
• Director of Research and Innovation, Sansum Diabetes Research Institute
• Consultant Physician, Bournemouth Diabetes and Endocrine Center, UK

INTERESTS

• Digital Health
• Food-as-Medicine
• Lifestyle intervention for prevention and treatment of cardiometabolic disease

ReSeARCH

• Tian T, Ho CN, Ayers AT, Aaron RE, Klonoff DC, Ahn DT, Kerr D, et al. Quantifying Environmental Waste From Diabetes Devices in the U.S. Diabetes Care. 2025 Mar 12: dc242522.
• Shah VN, Kerr D. What is a normal glucose value? Lancet Diabetes Endocrinol. 2025 Mar;13(3):172-174.
• Rhee CM, Gianchandani RY, Kerr D, et al. Consensus Report on the Use of Continuous Glucose Monitoring in Chronic Kidney Disease and Diabetes. J Diabetes Sci Technol. 2025 Jan;19(1):217-245.
• Ayers AT, Ho CN, Kerr D, et al. Artificial Intelligence to Diagnose Complications of Diabetes. J Diabetes Sci Technol. 2025 Jan;19(1):246-264.
• Ayers AT, Ho CN, Wong JC, Kerr D, Mader JK, Klonoff DC. The Benefits of Using Continuous Glucose Monitoring to Diagnose Type 1 Diabetes. J Diabetes Sci Technol. 2024 Oct 12:19322968241288923.
• Klonoff DC, Freckmann G, Pleus S, Kovatchev BP, Kerr D, et al. The Diabetes Technology Society Error Grid and Trend Accuracy Matrix for Glucose Monitors. J Diabetes Sci Technol. 2024 Nov;18(6):1346-1361.
• Sato Imuro SE, Sabharwal A, Bevier W, Kerr D. Evaluating HbA_1c-to-average glucose conversion with patient-specific kinetic models for diverse populations. Sci Rep. 2024 Sep 27;14(1):22098.
• Pai R, Barua S, Kim BS, McDonald M, Wierzchowska-McNew RA, Pai A, Deutz NEP, Kerr D, Sabharwal A. Estimating Breakfast Characteristics Using Continuous Glucose Monitoring and Machine Learning in Adults With or at Risk of Type 2 Diabetes. J Diabetes Sci Technol. 2024 Sep 23:19322968241274800.
• Kerr D, Ahn D, Waki K, Wang J, Breznen B, Klonoff DC. Digital Interventions for Self-Management of Type 2 Diabetes Mellitus: Systematic Literature Review and Meta-Analysis. J Med Internet Res. 2024 Jul 22;26:e55757.
• Kerr D, Ahn D, Waki K, Wang J, Breznen B, Klonoff DC. Digital Interventions for Self-Management of Type 2 Diabetes Mellitus: Systematic Literature Review and Meta-Analysis. J Med Internet Res. 2024 Jul 22;26:e55757. doi: 10.2196/55757.
• Piette JD, Lee KCS, Bosworth HB, Isaacs D, Cerrada CJ, Kainkaryam R, Liska J, Lee F, Kennedy A, Kerr D. Behavioral Engagement and Activation Model Study (BEAMS): A latent class analysis of adopters and non-adopters of digital health technologies among people with Type 2 diabetes. Transl Behav Med. 2024 Jul 27;14(8):491-498.
• Simonson GD, Criego A, Battelino T, Carlson AL, Choudhary P, Franc S, Gershenoff D, Grunberger G, Hirsch IB, Isaacs D, Johnson M, Kerr D, et al. Expert Panel Recommendations for a Standardized Ambulatory Glucose Profile Report for Connected Insulin Pens. Diabetes Technol Ther. 2024 Nov;26(11):814-822.
• Klonoff DC, Kim SH, Galindo RJ, Joseph JI, Garrett V, Gombar S, Aaron RE, Tian T, Kerr D. Risks of peri- and postoperative complications with glucagon-like peptide-1 receptor agonists. Diabetes Obes Metab. 2024 Aug;26(8):3128-3136
• Klonoff DC, Aaron RE, Tian T, DuNova AY, Pandey A, Rhee C, Fleming GA, Sacks DB, Pop-Busui R, Kerr D. Advanced Glycation Endproducts: A Marker of Long-term Exposure to Glycemia. J Diabetes Sci Technol. 2024 Mar 25:19322968241240436.
• Kerr D, Rajpura JR, Namvar T. Evaluating Patient and Provider Preferences for a Once-Weekly Basal Insulin in Adults with Type 2 Diabetes. Patient Prefer Adherence. 2024 Feb 14;18:411-424.
• Pai A, Santiago R, Glantz N, Bevier W, Barua S, Sabharwal A and Kerr D. Multimodal digital phenotyping for meal characterization in Hispanic/Latino adults with or at risk of type 2 diabetes. NPJ Digit Med. 2024 Jan 11;7(1):7.
• Kalyani R, Allende-Vigo M, Antinori-Lent, Close K, Das S, Deroze P, Edelman S, El Sayed N, Kerr D, Neumiller J and Norton A. Prioritizing patient experiences in the management of diabetes and its complications: An Endocrine Society Position Statement. J Clin Endocrinol Metab. 2024 Apr 19;109(5):1155-1178.
• Barua S, Sabharwal A, Glantz N, Conneely C, Larez A, Bevier W and Kerr D. A probabilistic reimagination of the dawn phenomenon. Insights from continuous glucose monitoring in an underserved population. Sci Reports. 2024 Feb 5; 14(1): 2915.
• Ebekozien O, Fantasia K, Farnoosh F, Sabharwal A and Kerr D. Technology and health inequities in diabetes care: How do we widen access to underserved populations & utilize technology to improve outcomes for all? Diabetes Obes Metab. 2024 Mar;26 Suppl 1(Suppl 1):3-13.
• Kerr D, Duncan I, Repetto E, Maroun R, Wu A, Perkins C, Bergman G and Giorgino F. Cost Analysis of Self-Monitoring Blood Glucose in Non Intensively Managed Type 2 Diabetes . Am J Manag Care. 2023 Dec;29(12):670-675. 
• Tian T, Aaron RE, Huang J, Yeung AM, Svensson J, Gentile S, Forbes A, Heinemann L, Seley J, Kerr D, Klonoff D. Lipohypertrophy and Insulin: An Update From the Diabetes Technology Society. J Diabetes Sci Technol. 2023 Aug 9th:19322968231187661.
• Sato E, Sabharwal A, Conneely C, Glantz N, Bevier W, Barua S, Pai A, Larez A and Kerr D. Farming for Life: Temporal changes in glycemia following a medical produce prescription program for predominantly Mexican American adults. Helyion Cell Press 2023; July 20^th
• Aaron RE, Tian T, Yeung AM, Huang J, Arreaza-Rubín GA, Ginsberg BH, Kompala T, Lee WA, Kerr D, et al. NIH Fifth Artificial Pancreas Workshop 2023: Meeting Report: The Fifth Artificial Pancreas Workshop: Enabling Fully Automation, Access, and Adoption. J Diabetes Sci Technol. 2024 Jan;18(1):215-239.
• J, Yeung AM, Klonoff DC, Abdel-Malek A, Ahn DT, Kerr D. People with Diabetes Using Insulin Flying Across Multiple Time Zones – Limitations and Opportunities for Diabetes Technologies. Endocr Pract. 2023 Oct;29(10):830-847.
• Klonoff DC, Yeung AM, Huang J, Espinoza JC, Raymond JK, Lee WA, Koliwad SK, Kerr D. Twenty-first century management of diabetes with shared telemedicine appointments. J Telemed Telecare. 2023 Jul 20:1357633X231184503.
• Duncan I, Kerr D, Aggarwal R, Huynh N. New Drugs for Obesity, Is the Excitement Affordable? Popul Health Manag. 2023 Oct;26(5):356-357.
• Yeung AM, Huang J, Pandey A, Hashim IA, Kerr D, et al. Biomarkers for the diagnosis of heart failure in people with diabetes: A consensus report from diabetes technology society. Prog Cardiovasc Dis. 2023 Jul-Aug;79:65-79.
• Huang J, Yeung AM, Kerr D, et al. Lipohypertrophy and Insulin. An Old Dog that Needs New Tricks. Endocr Pract. 2023 Aug;29(8):670-677
• Klonoff DC, Kerr D, Clark L. Barriers and Solutions to Trends and Disparities in Glycemic Control and Severe Hyperglycemia Among US Adults With Diabetes Using Insulin From 1988 to 2020. J Diabetes Sci Technol. 2023 May;17(3):866-867.
• Huang J, Yeung AM, Kerr D, Klonoff DC. Using ChatGPT to Predict the Future of Diabetes Technology. J Diabetes Sci Technol. 2023 May;17(3):853-854.
• Kerr D, Klonoff DC, Bergenstal RM, Choudhary P, Ji L. A Roadmap to an Equitable Digital Diabetes Ecosystem. Endocr Pract. 2023 Mar;29(3):179-184.